Cary Street Partners Investment Advisory’s Elevance Health ELV Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Buy	815 +25	+3%	+$9.27K	0.06%	288
2026 Q1	$231K	Buy	790 +27	+4%	+$8.87K	0.06%	323
2025 Q4	$267K	Buy	763 +9	+1%	+$3.04K	0.07%	271
2025 Q3	$244K	Sell	754 -48	-6%	-$14.9K	0.1%	226
2025 Q2	$312K	Buy	802 +146	+22%	+$58.7K	0.15%	157
2025 Q1	$285K	Buy	656 +21	+3%	+$8.43K	0.16%	153
2024 Q4	$234K	Sell	635 -10,799	-94%	-$4.52M	0.15%	153
2024 Q3	$5.95M	Sell	11,434 -991	-8%	-$529K	0.22%	111
2024 Q2	$6.73M	Buy	12,425 +5	+0%	+$2.64K	0.27%	97
2024 Q1	$6.44M	Sell	12,420 -123	-1%	-$61.2K	0.27%	99
2023 Q4	$5.91M	Buy	12,543 +471	+4%	+$218K	0.28%	96
2023 Q3	$5.26M	Sell	12,072 -288	-2%	-$131K	0.28%	98
2023 Q2	$5.49M	Sell	12,360 -139	-1%	-$64.1K	0.35%	75
2023 Q1	$5.75M	Sell	12,499 -139	-1%	-$66.1K	0.41%	66
2022 Q4	$6.48M	Buy	12,638 +2	+0%	+$1.01K	0.48%	61
2022 Q3	$5.74M	Buy	12,636 +1,589	+14%	+$760K	0.47%	59
2022 Q2	$5.33M	Buy	+11,047	New	+$5.47M	0.45%	65
2021 Q1	–	Sell	-2,873	Closed	-$923K	–	345
2020 Q4	$923K	Buy	2,873 +2,273	+379%	+$698K	0.18%	128
2020 Q3	$161K	Buy	+600	New	+$161K	0.03%	291

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cary Street Partners Investment Advisory's ELV Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Elevance Health (ELV) stake by 3.2% in Q2 2026, buying an estimated $9.27K and bringing the position to 815 shares worth $315K. The position accounts for 0.06% of the portfolio, ranked #288.

Cary Street Partners Investment Advisory first reported a position in ELV in Q3 2020 and has held it in 19 quarters since. The position peaked at $6.73M in Q2 2024. 1,098 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Cary Street Partners Investment Advisory held 815 shares of Elevance Health worth $315K as of Q2 2026.
Cary Street Partners Investment Advisory bought 25 Elevance Health shares in Q2 2026, an estimated $9.27K.
Elevance Health made up 0.06% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #288 holding.
Cary Street Partners Investment Advisory first reported a position in Elevance Health in Q3 2020 and has held it in 19 quarters since.
Cary Street Partners Investment Advisory's Elevance Health position peaked at $6.73M in Q2 2024.
1,098 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.